Quality of DNA-Technology Reagent Kits Confirmed by Leading Expert Organization

DNA-Technology has participated and successfully passed an external quality assessment by QCMD (Quality Control for Molecular Diagnostics) for the HPV PRESS-25 and HPV SURE-25 panels.

QCMD programs are globally recognized and are conducted in collaboration with leading expert centers and organizations, including the World Health Organization (WHO).

The study used the HPV QUANT-21 Quantitative REAL-TIME PCR Kit​, HPV SCREEN HR14(16-18-45) REAL-TIME PCR Kit​ and FEMOFLOR®II reagent kits, which demonstrated 100% result concordance across all samples in both programs.

It is particularly important to note that the kits showed high sensitivity and stable performance even for testing low-copy samples, confirming the accuracy and reliability of their analytical characteristics.

The HPV QUANT-21 Quantitative REAL-TIME PCR Kit allows not only to detect and type HPV but also to assess the viral load, which is crucial for monitoring the infection progression and evaluating the risk of pathology development.

These precise solutions enable the detection of a wide range of HPV types, including high-oncogenic risk types, playing a key role in the early diagnosis and prevention of oncological processes in the reproductive system.

The results of the external assessment confirm the high quality, international standards, and reliability of DNA-Technology's research in the field of molecular diagnostics.
The quality control reports can be accessed via the link.